Curiox Biosystems: Funding, Investors & Team (Oct 2026)
Curiox is a bioinstrumentation company spun out of the Agency for Science, Technology, and Research (A*STAR) in Singapore. Curiox has become a leader in the development and commercialization of innovative assay platforms based on its expertise in surface chemistry and engineering. Curiox’s vision is to accelerate the progress of life sciences, drug discovery and diagnostics through the miniaturization and improved automation of bioassays.
Curiox Biosystems has raised $15.0M across 1 funding round on record, the most recent a Series C of $15.0M announced in Mar 2022.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Curiox Biosystems Company Profile and Key Stats
Latest funding round on record: Mar 2022.
Curiox Biosystems Funding Rounds
Curiox Biosystems Founders and Leadership Team
Contact details for the Curiox Biosystems team: 1 of 1 has an email address on file.
Start 14-day free trial →Curiox Biosystems Funding Compared to Other Biotechnology Startups
Curiox Biosystems' latest round of $15.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Curiox Biosystems in Biotechnology and Singapore
Companies Similar to Curiox Biosystems
YouLabs is an early-stage, data-driven biotechnology and longevity technology company focused on shifting…
Volition is a worldwide life sciences organization creating straightforward, simple to utilize blood-based…
ImmunoScape is a company focused on immunomics, using a technology platform to analyze and characterize the…
Nuevocor, which has locations in both the United States and Singapore, is working on creating genetic…
Aevice Health Pte Ltd is a Singaporean company that originated from Nanyang Technological University and…
Mirxes is a biotech firm focused on uncovering, advancing, and providing precise preventive healthcare…
BioDefense introduces Bioshield, a product derived from edible ingredients designed to safeguard your food by…
Auristone delivers practical clinical insights through our epigenomics workflows, providing actionable…
ASLAN is a pharmaceutical company that develops novel medicines for global markets. It specializes in…
GDMC is a pharmaceutical organization that specializes in the production and development of genetic…
Meatiply, a company focused on food research, specializes in the creation and manufacturing of meat…
Empowering Healthier Meals by Harnessing the Best from Nature and Combining that our Knowledge of Food…
Curiox Biosystems Funding FAQs
What does Curiox Biosystems do?
Curiox is a bioinstrumentation company spun out of the Agency for Science, Technology, and Research (A*STAR) in Singapore. Curiox has become a leader in the development and commercialization of innovative assay platforms based on its expertise in surface chemistry and engineering. Curiox’s vision is to accelerate the progress of life sciences, drug discovery and diagnostics through the miniaturization and improved automation of bioassays.
How much funding has Curiox Biosystems raised?
Curiox Biosystems has raised $15.0M across 1 round on record. The most recent is a Series C of $15.0M announced in Mar 2022.
When did Curiox Biosystems last raise funding?
Curiox Biosystems' most recent funding round on record is a Series C of $15.0M, announced in Mar 2022.
Who is the CEO of Curiox Biosystems?
Namyong Kim is listed as CEO at Curiox Biosystems.
Where is Curiox Biosystems headquartered?
Curiox Biosystems is based in Singapore, Central Region, Singapore.
How many employees does Curiox Biosystems have?
Curiox Biosystems is in the 51-100 employee band.
How does Curiox Biosystems' funding compare to other Biotechnology startups?
Curiox Biosystems' latest round of $15.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Curiox Biosystems Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Curiox Biosystems is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.